What did Locate Technologies Limited announce?

Locate Technologies Limited (NZX: LOC) filed “LOC – Waiver from NZX Listing Rule 7.8.5(b)” with NZX on 6 November 2026, as a nzx compliance announcement.

When was it filed?
6 November 2026
Where is the original?
NZX announcement
Locate Technologies Limited logo

LOC – Waiver from NZX Listing Rule 7.8.5(b)

NZX Compliance6 November 2026LOCInformation Technology

Certificate of the Independent Directors
Pursuant to section 49(2) of the Companies Act 1993 (Act) and Waiver from NZX Listing Rule 7.8.5(b)

— Director options

To: NZ RegCo, Issuer Regulation

Issuer: Locate Technologies Limited (NZX: LOC) (Company)

Background

1 At its annual meeting on 23 November 2026, the Company will ask shareholders to approve, under NZX

Listing Rules 2.11.1 and 4.2.1, the issue of up to 500,000 options to each of Brett O’Riley (Resolution

7) and Janine Grainger (Resolution 8) (Options), on the terms set out in the notice of meeting dated 6

November 2026.

2 On 6 November 2026 NZ RegCo will grant the Company a waiver from NZX Listing Rule 7.8.5(b), which

otherwise would require the Company to provide an Appraisal Report to accompany the notice of

meeting in respect of the proposed issue of Options.

3 We, Drew Kelton and Michael Rosenbaum, are the Directors of the Company who do not participate in the

proposed issue and who are also independent Directors (Non-Interested Directors), and provide this

certificate as a condition of the waiver. Neither of us is associated with Brett O’Riley or Janine Grainger.

Certification

Pursuant to section 49 of the Act and as a condition for a waiver from NZX Listing Rule 7.8.5(b), and after

taking into account all relevant factors, the Non-Interested Directors below certify that, in their opinion:

(a) the waiver is in the best interests of, and fair and reasonable to, the Company and shareholders not

associated with Brett O’Riley or Janine Grainger; and

(b) the consideration and terms of the proposed issue of the Options are in the best interests of, and

fair and reasonable to, the Company and shareholders not associated with Brett O’Riley or Janine

Grainger; and

(c) in the absence of an Appraisal Report, the notice of meeting contains sufficient information to enable

shareholders to understand the terms of the Options and to make an informed decision on

Resolutions 7 and 8.

Basis for our opinion

In reaching this view, we considered:

(a) Exercise price: NZ$0.15 per share, a premium of 275% to the 20-day volume weighted average

price, so the Options have value to the holders only if the share price rises substantially.

(b) Vesting: the Options vest in three equal tranches on the first, second and third anniversaries of

grant, subject only to continued service, and expire four years after grant. Service-only vesting is

consistent with Recommendation 5.1 of the NZX Corporate Governance Code, which states that

performance-linked remuneration for non-executive directors may bias decision-making.

(c) Dilution: the 1,000,000 Options represent about 0.32% of the Company’s ordinary shares on issue.

(d) Value: an indicative Black-Scholes value of about NZ$10,313 per Director (NZ$20,626 in total),

about 19% of Brett O’Riley’s Director fees for the year ended 30 June 2026, or about 6% a year

over the three-year vesting period.


Locate Technologies Limited (NZX: LOC) — Certificate of the Independent Directors | Page 2

3480-6652-6290, v. 2

(e) Benchmarking: the options previously granted to the other Non-Executive Directors, in particular

the December 2024 options, which are exercisable at NZ$0.149 and expire on 20 December

2029.

(f) Process and voting: Brett O’Riley and Janine Grainger did not take part in the Board’s consideration

of, or vote on, the proposal, and they and their Associated Persons are disqualified from voting in

favour of the resolutions. Steve Orenstein did not take part in the Board’s consideration of, or vote

on, the proposal, as he is not an independent Director.

(g) Sufficiency of information: the notice of meeting sets out the full terms of the Options, the indicative

Black-Scholes value with every input, the full calculation and volatility workings (Appendix B), the

dilution, the benchmarking against the existing Director options, the value relative to cash Director

fees, and each recipient’s current holdings and fees. Shareholders and their advisers can

therefore test and re-run the valuation for themselves.

Signed


Drew Kelton

Independent Chair

Date:


Michael Rosenbaum

Independent Director

Date:


05 Nov 2026

05 Nov 2026

---

NZ RegCo

0



6 November 2026

NZ RegCo Decision

Locate Technologies Limited (LOC)

Application for a waiver from NZX Listing Rule 7.8.5(b)













NZ RegCo


1



Background

1. The information on which this decision is based is set out in Appendix One to this decision. This

waiver will not apply if that information is not, or ceases to be, full and accurate in all material

respects.

2. The NZX Listing Rule (Rules) to which this decision relates is set out in Appendix Two.

3. Capitalised terms that are not defined in this decision have the meanings given to them in the

Rules.

Waiver from Rule 7.8.5(b)

Decision

4. Subject to the conditions set out in paragraph 5 below, and on the basis that the information

provided by is complete and accurate in all material respects, NZ RegCo grants LOC a waiver

from Rule 7.8.5(b) to the extent that this Rule would otherwise require LOC to provide an

Appraisal Report to accompany its notice of meeting of shareholders to approve, among other

things, the issue of Options to two of its Directors.

5. The waiver in paragraph 4 above is provided on the conditions that:

a. the non-interested Directors of LOC certify to NZX, that in the opinion of each of the non

interested Directors, the waiver is in the best interests, and fair and reasonable to:

i. LOC, and,

ii. all LOC’s non-associated Shareholders,

b. the non-interested Directors of LOC certify to NZX, that in the opinion of each of the non

interested Directors, the consideration and terms of the issuance of the options is in the best

interest of, and fair and reasonable to:

i. LOC, and

ii. all non-associated Shareholders,

c. LOC’s non-interested Directors include in the certificate a summary of the core grounds for

the certifications given under each limb of conditions (a) and (b) described above; and

d. the waiver, and LOC’s reliance on the waiver, is disclosed in the Notice of Meeting and LOC's

next annual report.

Reasons

6. In coming to the decision to provide the waiver set out in paragraph 4 above, NZ RegCo has

considered that:

a. the policy behind Rule 7.8.5(b) is to ensure that shareholders are being asked to vote on a

resolution to approve a transaction to which Rule 7.8.5(b) applies receive the benefit of an

independent evaluation that allows them to understand and scrutinise the merits of that

transaction;

b. the granting of the waiver will not offend the policy behind Rule 7.8.5(b) because LOC has

submitted, and NZ RegCo has no reason not to accept, that:

i. the notice of meeting sets out the full option terms, the Black-Scholes value with every

input, the full calculation and volatility workings, dilution, the benchmarking against


NZ RegCo


2



existing director options, the value relative to cash fees, and each recipient's current

holdings and fees. The options will be granted with an exercise price of $0.15, which

represents a premium a premium of 275% to the 20-day VWAP of $0.04. The options

are therefore benchmarked to the market price of the underlying shares. Shareholders

can therefore assess the financial implications and fairness of the proposal without an

appraisal report;

ii. the purpose of the issuance is being disclosed in the notice of meeting, and the Directors

being offered the Options did not participate in LOC Board's consideration of, or vote on,

the proposal;

iii. the issue is 1,000,000 options (0.32% of shares on issue) with an indicative value of

about $20,600 in total. The exercise price is 3.75 times the current share price, so the

Directors benefit only if LOC’s share price rises substantially. There is no business, asset

or counterparty for an appraiser to evaluate; the only valuation of the option is disclosed

in the notice of meeting;

c. the certification conditions in this waiver provide comfort that the non-interested Directors

consider that:

i. the waiver is in the best interests of, and fair and reasonable to LOC and all of LOC’s

non-associated shareholders; and

ii. the consideration and terms of the issuance of the Options, is in the best interests of,

and fair and reasonable to LOC and all of LOC’s non-associated shareholders.; and

d. there is precedent for this decision.


NZ RegCo


3



Appendix One

1. Locate Technologies Limited (LOC) is a Listed Issuer with ordinary shares Quoted on the NZX

Main Board.

2. LOC will be seeking shareholder approval under Rules 2.11.1 and 4.2.1 at its annual shareholder

meeting to issue 500,000 options, each to Brett O’Riley and Janine Grainger, (“Options”) which

entitles the holder to acquire one ordinary share which will rank equally with LOC’s existing

shares on issue.

3. LOC considers that a modest equity component in non-Executive Director remuneration aligns

Directors’ interests with those of shareholders and allows LOC to attract and retain Directors of

the calibre it needs while conserving cash.

4. Drew Kelton and Michael Rosenbaum were granted options in December 2024, before LOC’s

NZX listing. Brett O’Riley and Janine Grainger do not currently hold options, and these grants

bring their remuneration into line with the other Non-Executive Directors. No further options are

proposed for Drew Kelton or Michael Rosenbaum.

5. The terms of the Options are as follows:

a. Issue Price: The Options will be issued for nil cash consideration.

b. Issue Date: The Options will be issued within 10 days after shareholder approval is granted.

c. Exercise Price: $0.15 per share.

d. Vesting: The Options vest in three equal tranches on the first, second and third anniversaries

of grant, subject only to the Director remaining in office, and expire four years after grant.

6. Under Rule 7.8.5(b), a notice of meeting to consider a resolution of the nature referred to in Rule

7.8.4 must be accompanied by an Appraisal Report if more than 50% of the Financial Products to

be issued are intended or likely to be acquired by Directors or Associated Persons of Directors.

The issue of Options triggers this requirement.

7. LOC is seeking a waiver from the requirement to prepare an Appraisal Report under Rule 7.8.5(b)

in respect of the Director Options.


NZ RegCo


4



Appendix Two

Rule 7.8 Notices of Meeting

Rule 7.8.5

A notice of meeting to consider a resolution of the nature referred to in Rule 7.8.4 (other than a

resolution to permit an issue under Rule 4.7.1) must be accompanied by an Appraisal Report if:

(a) the resolution is required by Rule 4.13;

(b) more than 50% of the Financial Products to be issued are intended or likely to be acquired by

Directors or Associated Persons of Directors; or

(c) more than 50% of the Financial Products to be acquired or redeemed or the financial assistance to

be given is intended or likely to go to Directors or Associated Persons of Directors

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.